1.Efficacy of tegoprazan versus esomeprazole in treatment of reflux esophagitis and analysis of influencing factors for treatment failure
Yanhong ZHU ; Shangzhi YAO ; Feng JU ; Meilin LI ; Xiaowei WANG
Journal of Clinical Medicine in Practice 2025;29(13):61-65
Objective To compare the efficacy of tegoprazan and esomeprazole in treatment of reflux esophagitis(RE)and analyze the influencing factors for treatment failure.Methods A total of 120 RE patients were selected as study subjects and divided into control group(treated with esome-prazole)and observation group(treated with tegoprazan)using random number table method,with 60 cases in each group.The clinical efficacy and gastroscopic efficacy of the two groups were com-pared.Based on the gastroscopic assessment results,the patients were divided into failure group(26 cases)and success group(94 cases).The clinical data of the failure group and the success group were collected and compared.Multivariate Logistic regression analysis was used to screen the influen-cing factors for treatment failure in RE patients.Results The total clinical effective rate in the ob-servation group was 93.33%(56/60),which was higher than 76.67%(46/60)in the control group(P<0.05).The total effective rate under gastroscopy in the observation group was 88.33%(53/60),which was higher than 68.33%(41/60)in the control group,and the difference was statistically significant(P<0.05).The proportions of patients with body mass index(BMI)>28 kg/m2,diabe-tes,a family history,Helicobacter pylori(Hp)infection,Los Angeles classification(LA classifica-tion)of gastroesophageal reflux disease(GERD)grade C to D,and treated with esomeprazole in the failure group were all higher than those in the success group,and the differences were statistically significant(P<0.05).Multivariate Logistic regression analysis showed that BMI>28 kg/m2,con-comitant diabetes,LA classification grade C to D,and treatment with esomeprazole were all inde-pendent risk factors for treatment failure in RE patients(P<0.05).Conclusion Tegoprazan has a significant clinical effect in treatment of RE,and its efficacy is superior to that of esomeprazole.BMI>28 kg/m2,concomitant diabetes,LA classification grade C to D,and treatment with esome-prazole are all risk factors for treatment failure in RE patients.
2.Clinical value of serum levels of MC-CP,CCL26 and DcR3 in the diagnosis of COPD complicated with OSAS
Liping CHEN ; Yongxing SHI ; Yanhong CHEN ; Ping FENG ; Changhong ZHANG ; Weijia LIN ; Baoli XIANG
Basic & Clinical Medicine 2025;45(1):76-80
Objective To investigate the clinical value of serum mast cell carboxypeptidase(MC-CP),C-C motif chemokine 26(CCL26),and decoy receptor 3(DcR3)in the diagnosis of obstructive sleep apnea syndrome(OSAS)in chronic obstructive pulmonary disease(COPD).Methods Ninety COPD patients who visited the First Affiliated Hospital of Hebei North University from January 2021 to January 2023 were collected.Among them,48 patients with simple COPD were included in the COPD group,and 42 patients with COPD combined with OSAS were included in the COPD-OSAS group.During the same period,48 healthy volunteers who underwent physical examination in that Hospital of Hebei North collected as the control group.Enzyme linked immunosorbent assay(ELISA)was applied to detect serum level of MC-CP,CCL26,and DcR3.Receiver operating characteristic(ROC)curve was applied to analyze the clinical value of serum level of MC-CP,CCL26,and DcR3 in the diag-nosis of COPD complicated with OSAS.Multivariate Logistic regression was applied to analyze the influencing fac-tors of COPD complicated with OSAS.Results Compared with the control group,the smoking index,C-reactive protein(CRP)and white blood cell count(WBC)in the COPD and COPD-OSAS groups increased obviously in sequence,the ratio of forced expiratory volume in first second to forced vital capacity(FEV1/FVC)decreased obviously in sequence(P<0.05);Compared with the control group,the level of MC-CP,CCL26,and DcR3 in patients with COPD and COPD-OSAS increased significantly in sequence(P<0.05);The combination of serum MC-CP,CCL26 and DcR3 had a higher area under the curve(AUC)for the diagnosis of COPD complicated with OSAS compared to the individual diagnosis(Z=4.066,P<0.001;Z=2.391,P<0.05;Z=2.353,P<0.05).Multivariate Logistic regression analysis showed that smoking index,serum level of MC-CP,CCL26 and DcR3 were influencing factors for COPD complicated with OSAS(P<0.05).Conclusions The simultane-ously increased expression of MC-CP,CCL26 and DcR3 in the serum of COPD may support clinical diagnostic of COPD patients with OSAS.
3.Efficacy of allogeneic hematopoietic stem cell transplantation in treating post-chronic aplastic anemia induced myelodysplastic syndrome
Yue SHI ; Yanhong YAO ; Jingjing YAO ; Zhibin LIU ; Lirui ZHANG ; Feng GAO ; Xiaoyu LI ; Shuqing FENG
Academic Journal of Naval Medical University 2025;46(9):1229-1234
Objective To compare the efficacies of allogeneic hematopoietic stem cell transplantation(allo-HSCT)in the treatment of post-chronic aplastic anemia(CAA)myelodysplastic syndrome(MDS)and primary MDS.Methods A retrospective analysis was conducted on 32 patients who received allo-HSCT treatment in Department of Hematology,North China University of Science and Technology Affiliated Hospital between Feb.2012 and Feb.2022,including 12 patients with post-CAA MDS and 20 patients with primary MDS.The overall survival rate,cumulative incidence of relapse(CIR)rate,non-relapse mortality(NRM)rate,and event-free survival rate were compared between the 2 groups.Results The median follow-up time for CAA to progress to MDS was 120(72-180)months.All the patients were followed up for 36(3-79)months after allo-HSCT.The 3-year overall survival rate of the post-CAA MDS group was significantly higher than that of the primary MDS group(83.8%vs 45.0%,P=0.035).The 3-year CIR of the post-CAA MDS group was significantly lower than that of the primary MDS group(16.7%vs 55.0%,P=0.021).There was no significant difference in the event-free survival rates or NRM rates between the 2 groups(both P>0.05).Conclusion The post-CAA MDS patients have better survival after allo-HSCT than the primary MDS patients.Early allo-HSCT treatment may improve the prognosis.
4.Diagnostic value of combined detection of serum TNF-α,IL-10 and Helicobacter pylori infection for early gastric cancer
Yue YANG ; Jianfeng HUO ; Feng LI ; Yanhong WANG ; Shibo SHANG
Tianjin Medical Journal 2025;53(2):161-165
Objective To explore changes of serum levels of tumor necrosis factor alpha(TNF-α),interleukin-10(IL-10),and Helicobacter pylori(HP)positivity rate in patients with early gastric cancer,and the diagnostic value of three factors in early gastric cancer.Methods A total of 312 patients with gastric discomfort were included in this study and used as the observation subjects.Patients were divided into the gastritis group(n=100),the precancerous lesion group(n=110)and the early gastric cancer group(n=102)based on their gastroscopy.Enzyme linked immunosorbent assay(ELISA)was used to detect serum levels of TNF-α and IL-10.HP infection was detected in the three groups.Multivariate Logistic regression was used to analyze influencing factors of early gastric cancer.Receiver operating characteristic(ROC)curve analysis was used to evaluate the diagnostic value of serum TNF-α,IL-10 and HP infection in early gastric cancer.Results The levels of TNF-α,IL-10 and HP positivity rate were increased in the gastritis group,the precancerous lesion group and the early gastric cancer group in sequence(all P<0.05).Hot food,heavy salt,pepsinogen Ⅱ(PG Ⅱ),HP positivity and elevated levels of TNF-α and IL-10 were independent risk factors for early gastric cancer,while elevated PGⅠ was a protective factor(all P<0.05).The areas under the curve for serum TNF-α,IL-10,HP infection and their combined diagnosis of early gastric cancer were 0.694,0.698,0.763,and 0.870,respectively.The combined diagnostic efficacy of the three was better than that of individual diagnosis(all P<0.05).Conclusion The serum levels of TNF-α,IL-10 and HP positivity rate are significantly increased in patients with early gastric cancer,and all three have certain diagnostic value for early gastric cancer.
5.Current status of human immunodeficiency virus testing and residual risk in 17 provincial blood centers in China from 2015 to 2024
Siqi WU ; Ying LIU ; Shuo ZHANG ; Yujun LI ; Binbin ZOU ; Lin WANG ; Fei TANG ; Weiping FENG ; Yanhong WAN ; Yanyan LIU ; Ying LI ; Chen XIAO ; Tao WEN ; Hanshi GONG ; Shan FU ; Wenjia HU ; Yan QIU
Chinese Journal of Infectious Diseases 2025;43(10):590-598
Objective:To analyze the human immunodeficiency virus (HIV) screening status and the resulting residual risk (RR) among blood donors across 17 provincial blood centers in China.Methods:This study used a cross-sectional study. Data on HIV infection markers per 100 000 first-time donors (FD) and repeat donors (RD) from January 2015 to December 2024 were extracted from the National Blood Establishment Performance Comparison Information Management System. Questionnaires were used to collect each center′s HIV screening strategy, algorithm, serological test (ST) kit manufacturers, gray-zone setting for ST, and nucleic acid test (NAT) modality, method, and platform. The incidence-window-period model was used to calculate the residual risk for first-time donors (RR FD), repeat donors (RR RD), and total donors (RR TD) at each center. Horizontal and vertical analysis of RR FD, RR RD, and RR TD across centers and years were performed. Results:All 17 centers applied the same HIV screening strategy which was two rounds of ST followed by one round of NAT. Eight of them operated a single screening algorithm, six employed two algorithms and three used three. Eleven centers used both imported and domestic ST kits, five relied on domestic ST kits only, and one used imported ST kits only, while four centers never set a grey zone for ST throughout the decade. For NAT modalities, eight centers adopted both individual nucleic acid test (ID-NAT) and minipool nucleic acid test (MP-NAT), eight used MP-NAT only and one used ID-NAT only. Seven centers combined transcription mediated amplification (TMA) and polymerase chain reaction (PCR), nine used PCR only and one used TMA only, and fourteen centers ran both imported and domestic NAT systems, two used imported systems only and one used a domestic system only. Over the ten-year period, the mean RR FD across the centers ranged from 2.22 to 12.33 per 10 6 person-years, RR RD from 0.83 to 3.29 per 10 6 person-years and RR TD from 1.59 to 9.29 per 10 6 person-years, with center Z4 consistently showing the lowest values for all three metrics and center U4 recording the highest RR FD and RR TD, while center D2 had the highest RR RD. In 2024 compared with 2015, eleven centers achieved a lower RR FD and ten centers achieved lower RR RD and RR TD. The RR FD and RR TD of centers W2 and U4 displayed pronounced fluctuations and an upward trend in recent years. Conclusions:The 17 provincial blood centers maintain consistent HIV screening strategies, while demonstrating variations in screening algorithm, ST kit manufacturers, NAT modalities, methods, and platform. And the RR FD, RR RD, and RR TD differ across centers. Although most centers show declining trend in RR over the ten-year period, some centers exhibite data fluctuations with a rising trend, suggesting potential for further optimization of HIV screening protocols.
6.Diagnostic value of combined detection of serum TNF-α,IL-10 and Helicobacter pylori infection for early gastric cancer
Yue YANG ; Jianfeng HUO ; Feng LI ; Yanhong WANG ; Shibo SHANG
Tianjin Medical Journal 2025;53(2):161-165
Objective To explore changes of serum levels of tumor necrosis factor alpha(TNF-α),interleukin-10(IL-10),and Helicobacter pylori(HP)positivity rate in patients with early gastric cancer,and the diagnostic value of three factors in early gastric cancer.Methods A total of 312 patients with gastric discomfort were included in this study and used as the observation subjects.Patients were divided into the gastritis group(n=100),the precancerous lesion group(n=110)and the early gastric cancer group(n=102)based on their gastroscopy.Enzyme linked immunosorbent assay(ELISA)was used to detect serum levels of TNF-α and IL-10.HP infection was detected in the three groups.Multivariate Logistic regression was used to analyze influencing factors of early gastric cancer.Receiver operating characteristic(ROC)curve analysis was used to evaluate the diagnostic value of serum TNF-α,IL-10 and HP infection in early gastric cancer.Results The levels of TNF-α,IL-10 and HP positivity rate were increased in the gastritis group,the precancerous lesion group and the early gastric cancer group in sequence(all P<0.05).Hot food,heavy salt,pepsinogen Ⅱ(PG Ⅱ),HP positivity and elevated levels of TNF-α and IL-10 were independent risk factors for early gastric cancer,while elevated PGⅠ was a protective factor(all P<0.05).The areas under the curve for serum TNF-α,IL-10,HP infection and their combined diagnosis of early gastric cancer were 0.694,0.698,0.763,and 0.870,respectively.The combined diagnostic efficacy of the three was better than that of individual diagnosis(all P<0.05).Conclusion The serum levels of TNF-α,IL-10 and HP positivity rate are significantly increased in patients with early gastric cancer,and all three have certain diagnostic value for early gastric cancer.
7.Current status of human immunodeficiency virus testing and residual risk in 17 provincial blood centers in China from 2015 to 2024
Siqi WU ; Ying LIU ; Shuo ZHANG ; Yujun LI ; Binbin ZOU ; Lin WANG ; Fei TANG ; Weiping FENG ; Yanhong WAN ; Yanyan LIU ; Ying LI ; Chen XIAO ; Tao WEN ; Hanshi GONG ; Shan FU ; Wenjia HU ; Yan QIU
Chinese Journal of Infectious Diseases 2025;43(10):590-598
Objective:To analyze the human immunodeficiency virus (HIV) screening status and the resulting residual risk (RR) among blood donors across 17 provincial blood centers in China.Methods:This study used a cross-sectional study. Data on HIV infection markers per 100 000 first-time donors (FD) and repeat donors (RD) from January 2015 to December 2024 were extracted from the National Blood Establishment Performance Comparison Information Management System. Questionnaires were used to collect each center′s HIV screening strategy, algorithm, serological test (ST) kit manufacturers, gray-zone setting for ST, and nucleic acid test (NAT) modality, method, and platform. The incidence-window-period model was used to calculate the residual risk for first-time donors (RR FD), repeat donors (RR RD), and total donors (RR TD) at each center. Horizontal and vertical analysis of RR FD, RR RD, and RR TD across centers and years were performed. Results:All 17 centers applied the same HIV screening strategy which was two rounds of ST followed by one round of NAT. Eight of them operated a single screening algorithm, six employed two algorithms and three used three. Eleven centers used both imported and domestic ST kits, five relied on domestic ST kits only, and one used imported ST kits only, while four centers never set a grey zone for ST throughout the decade. For NAT modalities, eight centers adopted both individual nucleic acid test (ID-NAT) and minipool nucleic acid test (MP-NAT), eight used MP-NAT only and one used ID-NAT only. Seven centers combined transcription mediated amplification (TMA) and polymerase chain reaction (PCR), nine used PCR only and one used TMA only, and fourteen centers ran both imported and domestic NAT systems, two used imported systems only and one used a domestic system only. Over the ten-year period, the mean RR FD across the centers ranged from 2.22 to 12.33 per 10 6 person-years, RR RD from 0.83 to 3.29 per 10 6 person-years and RR TD from 1.59 to 9.29 per 10 6 person-years, with center Z4 consistently showing the lowest values for all three metrics and center U4 recording the highest RR FD and RR TD, while center D2 had the highest RR RD. In 2024 compared with 2015, eleven centers achieved a lower RR FD and ten centers achieved lower RR RD and RR TD. The RR FD and RR TD of centers W2 and U4 displayed pronounced fluctuations and an upward trend in recent years. Conclusions:The 17 provincial blood centers maintain consistent HIV screening strategies, while demonstrating variations in screening algorithm, ST kit manufacturers, NAT modalities, methods, and platform. And the RR FD, RR RD, and RR TD differ across centers. Although most centers show declining trend in RR over the ten-year period, some centers exhibite data fluctuations with a rising trend, suggesting potential for further optimization of HIV screening protocols.
8.The Implications of the Four Traditional Medical Education Systems in the World and for the Traditional Chinese Medicine
Xiuyan LI ; Dongfei FENG ; Yanhong WANG ; Zhixin YANG ; Qingxia GUAN ; Rui WANG ; Yufei FENG ; Weinan LI ; Yan ZHANG
Chinese Hospital Management 2024;44(8):84-88
Traditional Chinese medicine,ancient Greek medicine,Ayurvedic medicine,and Arab medicine are recognized as the four major traditional medicines in the world.It reviews the education and training systems of the four major traditional medicines and finds that traditional Chinese medicine focuses on the teacher-student relation-ship and the combination of theory and practice;Ancient Greek medicine was mainly characterized by strong theoreti-cal research and experimental observation;Ayurveda highly values cultural identity as its main characteristic;Arab medicine attaches great importance to cultural exchange and practical promotion.It suggests promoting innovative de-velopment,strengthening practical teaching,improving teaching quality,strengthening international exchanges and cooperation,and increasing public acceptance abroad.
9.The Implications of the Four Traditional Medical Education Systems in the World and for the Traditional Chinese Medicine
Xiuyan LI ; Dongfei FENG ; Yanhong WANG ; Zhixin YANG ; Qingxia GUAN ; Rui WANG ; Yufei FENG ; Weinan LI ; Yan ZHANG
Chinese Hospital Management 2024;44(8):84-88
Traditional Chinese medicine,ancient Greek medicine,Ayurvedic medicine,and Arab medicine are recognized as the four major traditional medicines in the world.It reviews the education and training systems of the four major traditional medicines and finds that traditional Chinese medicine focuses on the teacher-student relation-ship and the combination of theory and practice;Ancient Greek medicine was mainly characterized by strong theoreti-cal research and experimental observation;Ayurveda highly values cultural identity as its main characteristic;Arab medicine attaches great importance to cultural exchange and practical promotion.It suggests promoting innovative de-velopment,strengthening practical teaching,improving teaching quality,strengthening international exchanges and cooperation,and increasing public acceptance abroad.
10.The Implications of the Four Traditional Medical Education Systems in the World and for the Traditional Chinese Medicine
Xiuyan LI ; Dongfei FENG ; Yanhong WANG ; Zhixin YANG ; Qingxia GUAN ; Rui WANG ; Yufei FENG ; Weinan LI ; Yan ZHANG
Chinese Hospital Management 2024;44(8):84-88
Traditional Chinese medicine,ancient Greek medicine,Ayurvedic medicine,and Arab medicine are recognized as the four major traditional medicines in the world.It reviews the education and training systems of the four major traditional medicines and finds that traditional Chinese medicine focuses on the teacher-student relation-ship and the combination of theory and practice;Ancient Greek medicine was mainly characterized by strong theoreti-cal research and experimental observation;Ayurveda highly values cultural identity as its main characteristic;Arab medicine attaches great importance to cultural exchange and practical promotion.It suggests promoting innovative de-velopment,strengthening practical teaching,improving teaching quality,strengthening international exchanges and cooperation,and increasing public acceptance abroad.

Result Analysis
Print
Save
E-mail